Aire-dependent genes undergo Clp1-mediated 3'UTR shortening associated with higher transcript stability in the thymus

  1. Clotilde Guyon
  2. Nada Jmari
  3. Francine Padonou
  4. Yen-Chin Li
  5. Olga Ucar
  6. Noriyuki Fujikado
  7. Fanny Coulpier
  8. Christophe Blanchet
  9. David E Root
  10. Matthieu Giraud  Is a corresponding author
  1. Institut Cochin, INSERM U1016, France
  2. Université de Nantes, Inserm, Centre de Recherche en Transplantation et Immunologie, UMR 1064, ITUN, France
  3. German Cancer Research Center, Germany
  4. Harvard Medical School, United States
  5. Institut de Biologie de l'Ecole Normale Supérieure, France
  6. Institut Français de Bioinformatique, CNRS UMS 3601, France
  7. Broad Institute of Harvard and MIT, United States

Abstract

The ability of the immune system to avoid autoimmune disease relies on tolerization of thymocytes to self-antigens whose expression and presentation by thymic medullary epithelial cells (mTECs) is controlled predominantly by Aire at the transcriptional level and possibly regulated at other unrecognized levels. Aire-sensitive gene expression is influenced by several molecular factors, some of which belong to the 3'end processing complex, suggesting they might impact transcript stability and levels through an effect on 3'UTR shortening. We discovered that Aire-sensitive genes display a pronounced preference for short-3'UTR transcript isoforms in mTECs, a feature preceding Aire's expression and correlated with the preferential selection of proximal polyA sites by the 3'end processing complex. Through an RNAi screen and generation of a lentigenic mouse, we found that one factor, Clp1, promotes 3'UTR shortening associated with higher transcript stability and expression of Aire-sensitive genes, revealing a post-transcriptional level of control of Aire-activated expression in mTECs.

Data availability

All RNAseq and microarray data are deposited in the NCBI Gene Expression Omnibus database (GEO).

The following data sets were generated
The following previously published data sets were used

Article and author information

Author details

  1. Clotilde Guyon

    Immunology, Institut Cochin, INSERM U1016, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  2. Nada Jmari

    Immunology, Institut Cochin, INSERM U1016, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  3. Francine Padonou

    Université de Nantes, Inserm, Centre de Recherche en Transplantation et Immunologie, UMR 1064, ITUN, Nantes, France
    Competing interests
    The authors declare that no competing interests exist.
  4. Yen-Chin Li

    Immunology, Institut Cochin, INSERM U1016, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  5. Olga Ucar

    Developmental Immunology, German Cancer Research Center, Heidelberg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  6. Noriyuki Fujikado

    Department of Microbiology and Immunobiology, Harvard Medical School, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Fanny Coulpier

    Genomic platform, Institut de Biologie de l'Ecole Normale Supérieure, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  8. Christophe Blanchet

    IFB-Core, Institut Français de Bioinformatique, CNRS UMS 3601, Evry, France
    Competing interests
    The authors declare that no competing interests exist.
  9. David E Root

    Broad Institute of Harvard and MIT, Cambridge, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Matthieu Giraud

    Université de Nantes, Inserm, Centre de Recherche en Transplantation et Immunologie, UMR 1064, ITUN, Nantes, France
    For correspondence
    matthieu.giraud@inserm.fr
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1208-9677

Funding

Agence Nationale de la Recherche (Research grant,2011-CHEX-001-R12004KK)

  • Matthieu Giraud

European Commission (Career Integration Grant,CIG PCIG9-GA-2011-294212)

  • Matthieu Giraud

Agence Nationale de la Recherche (Investissements d'Avenir,ANR-10-INBS-09)

  • Fanny Coulpier

Agence Nationale de la Recherche (Investissements d'Avenir,ANR-11-INBS-0013)

  • Christophe Blanchet

Fondation pour la Recherche Médicale (Graduate Student Fellowship,FDT20150532551)

  • Clotilde Guyon

Fondation pour la Recherche Médicale (Bioinformatics engineer grant)

  • Yen-Chin Li

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Clare Blackburn, MRC Centre for Regenerative Medicine, University of Edinburgh, United Kingdom

Ethics

Animal experimentation: Mice were housed, bred and manipulated in specific-pathogen-free conditions at Cochin Institute according to the guidelines of the French Veterinary Department and under procedures approved by the Paris-Descartes Ethical Committee for Animal Experimentation (decision CEEA34.MG.021.11 or APAFIS #3683 No 2015062411489297 for lentigenic mouse generation)

Version history

  1. Received: October 23, 2019
  2. Accepted: April 24, 2020
  3. Accepted Manuscript published: April 27, 2020 (version 1)
  4. Accepted Manuscript updated: April 29, 2020 (version 2)
  5. Version of Record published: May 7, 2020 (version 3)

Copyright

© 2020, Guyon et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,186
    views
  • 156
    downloads
  • 13
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Clotilde Guyon
  2. Nada Jmari
  3. Francine Padonou
  4. Yen-Chin Li
  5. Olga Ucar
  6. Noriyuki Fujikado
  7. Fanny Coulpier
  8. Christophe Blanchet
  9. David E Root
  10. Matthieu Giraud
(2020)
Aire-dependent genes undergo Clp1-mediated 3'UTR shortening associated with higher transcript stability in the thymus
eLife 9:e52985.
https://doi.org/10.7554/eLife.52985

Share this article

https://doi.org/10.7554/eLife.52985

Further reading

    1. Genetics and Genomics
    2. Neuroscience
    Céline Petitgas, Laurent Seugnet ... Serge Birman
    Research Article

    Adenine phosphoribosyltransferase (APRT) and hypoxanthine-guanine phosphoribosyltransferase (HGPRT) are two structurally related enzymes involved in purine recycling in humans. Inherited mutations that suppress HGPRT activity are associated with Lesch–Nyhan disease (LND), a rare X-linked metabolic and neurological disorder in children, characterized by hyperuricemia, dystonia, and compulsive self-injury. To date, no treatment is available for these neurological defects and no animal model recapitulates all symptoms of LND patients. Here, we studied LND-related mechanisms in the fruit fly. By combining enzymatic assays and phylogenetic analysis, we confirm that no HGPRT activity is expressed in Drosophila melanogaster, making the APRT homolog (Aprt) the only purine-recycling enzyme in this organism. Whereas APRT deficiency does not trigger neurological defects in humans, we observed that Drosophila Aprt mutants show both metabolic and neurobehavioral disturbances, including increased uric acid levels, locomotor impairments, sleep alterations, seizure-like behavior, reduced lifespan, and reduction of adenosine signaling and content. Locomotor defects could be rescued by Aprt re-expression in neurons and reproduced by knocking down Aprt selectively in the protocerebral anterior medial (PAM) dopaminergic neurons, the mushroom bodies, or glia subsets. Ingestion of allopurinol rescued uric acid levels in Aprt-deficient mutants but not neurological defects, as is the case in LND patients, while feeding adenosine or N6-methyladenosine (m6A) during development fully rescued the epileptic behavior. Intriguingly, pan-neuronal expression of an LND-associated mutant form of human HGPRT (I42T), but not the wild-type enzyme, resulted in early locomotor defects and seizure in flies, similar to Aprt deficiency. Overall, our results suggest that Drosophila could be used in different ways to better understand LND and seek a cure for this dramatic disease.

    1. Genetics and Genomics
    Gbolahan Bamgbose, Guillaume Bordet ... Alexei Tulin
    Research Article

    PARP-1 is central to transcriptional regulation under both normal and stress conditions, with the governing mechanisms yet to be fully understood. Our biochemical and ChIP-seq-based analyses showed that PARP-1 binds specifically to active histone marks, particularly H4K20me1. We found that H4K20me1 plays a critical role in facilitating PARP-1 binding and the regulation of PARP-1-dependent loci during both development and heat shock stress. Here, we report that the sole H4K20 mono-methylase, pr-set7, and parp-1 Drosophila mutants undergo developmental arrest. RNA-seq analysis showed an absolute correlation between PR-SET7- and PARP-1-dependent loci expression, confirming co-regulation during developmental phases. PARP-1 and PR-SET7 are both essential for activating hsp70 and other heat shock genes during heat stress, with a notable increase of H4K20me1 at their gene body. Mutating pr-set7 disrupts monomethylation of H4K20 along heat shock loci and abolish PARP-1 binding there. These data strongly suggest that H4 monomethylation is a key triggering point in PARP-1 dependent processes in chromatin.